The invention was made with Government support, and the Government has certain rights in this invention under grants from the National Institutes of Health AI26872 and CA34183.
Entry |
---|
Nadler et al., "B Cell Origin of Non-T Cell Acute Lymphoblastic Leukemia A Model for Discrete Stages of Neoplastic and Normal Pre-B Cell Differentiation," J. Clin. Invest. 74: 332-340 (1984). |
Tedder et al., "Antibodies Reactive with the B1 Molecule Inhibity Cell Cycle Progression but not Activation of Human B lymphocytes," Eur. J. Immunol. 16: 881-887 (1986). |
MacDougall et al., "Detection of Ligand-Activated Conductive Ca.sup.21 Channels in Human B Lymphocytes," Cell 54: 229-234 (1988). |
Fukishima et al., "Voltage-gated Ca.sup.2+ Channel in Mouse Myeloma Cells," Proc. Natl. Acad. Sci. U.S.A. 80: 2240-2242 (1983). |
Dugas, "Human B Cell Activation: Selective Sensitivity of the Early Stages to Calcium Channel-Blocking Drugs," Eur. J. Immunol. 16: 162-167 (1986). |
Tedder et al., "The B Cell Surface Molecule B1 is Functionally Linked with B Cell Activation and Differentiation," The Journal of Immunology 135: 973-979 (1985). |
Tedder et al., "Isolation and Structure of a cDNA Encoding the Bl (CD20) Cell-Surface Antigen of Human B Lymphocytes," Proc. Natl. Acad. Sci. U.S.A. 85: 208-212 (1988). |
Tedder et al., "Cloning of a Complementary DNA Encoding a New Mouse B Lumphocyte Differentiation Antigen, Homologous to the Human B1 (CD20) Antigen and Localization of the Gene to Chromosome 19," The Journal of Immunology 141: 4388-4394 (1988). |
Tedder et al., "Phosphorylation of the B1 (CD20) Molecule by Normal and Malignmant Human B Lymphocytes," The Journal of Biological Chemistry 263: 10009-10015 (1988). |